{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05703243",
            "orgStudyIdInfo": {
                "id": "DINOSAur II"
            },
            "organization": {
                "fullName": "Glendale Adventist Medical Center d/b/a Adventist Health Glendale",
                "class": "OTHER"
            },
            "briefTitle": "Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting (\"DINOSAur II\")",
            "officialTitle": "Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting. (\"DINOSAur II\")",
            "acronym": "DINOSAur II",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "discovering-novel-cancer-treatment-options-using-a-comprehensive-ngs-based-liquid-molecular-testing-panel-in-the-community-setting-dinosaur-ii"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-02-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-01-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-01-10",
            "studyFirstSubmitQcDate": "2023-01-25",
            "studyFirstPostDateStruct": {
                "date": "2023-01-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-03-01",
            "lastUpdatePostDateStruct": {
                "date": "2023-03-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Mihran Shirinian",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Glendale Adventist Medical Center d/b/a Adventist Health Glendale"
            },
            "leadSponsor": {
                "name": "Glendale Adventist Medical Center d/b/a Adventist Health Glendale",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Guardant Health, Inc.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To prospectively identify cancer patients whose tumors express specific molecular markers targeted by therapeutic agents from a comprehensive l i q u i d molecular test, for the purpose of selecting the most clinically appropriate treatment in a pragmatic two arm trial."
        },
        "conditionsModule": {
            "conditions": [
                "Stage III Solid Tumors",
                "Stage IV Solid Tumors"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "2 Years",
            "designInfo": {
                "observationalModel": "CASE_CONTROL",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 572,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Active",
                    "description": "Newly diagnosed cancer patients.",
                    "interventionNames": [
                        "Diagnostic Test: Comprehensive liquid molecular panel test",
                        "Other: EORTC QLQ-30"
                    ]
                },
                {
                    "label": "Control",
                    "description": "Historically diagnosed cancer patients."
                }
            ],
            "interventions": [
                {
                    "type": "DIAGNOSTIC_TEST",
                    "name": "Comprehensive liquid molecular panel test",
                    "description": "Lab test",
                    "armGroupLabels": [
                        "Active"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "EORTC QLQ-30",
                    "description": "Quality of life questionnaire",
                    "armGroupLabels": [
                        "Active"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (QLQ-C30)",
                    "description": "The EORTC Core Questionnaire (QLQ-C30) includes six clearly distinguishable functioning scales that have been thoroughly tested and validated on an international level and that are available in 110 different language versions. The scaling of items is 1 (Not at all) to 4 (Very much), 1 (Very poor) to 7 (Excellent). The higher the score the better the quality of life.",
                    "timeFrame": "2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Compare the proportion of enrolling in clinical trials",
                    "description": "To compare the proportion of enrolling in clinical trials between cancers patients who received the CLMT versus cancer patients with no CLMT.",
                    "timeFrame": "2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who have given informed consent in accordance with the methods and procedures of this study\n* Diagnosis of cancer (stage 3 and stage 4; solid tumors only) requiring medical care\n* Patients who have not received treatment related to his/her cancer\n* Patients who are willing to sign a release of medical records to the research team\n* Male and female patients \u226518 years of age\n* Patients under oncology care\n* Sufficient clinical status for collection of blood sample within usual care\n\nExclusion Criteria:\n\n* Patients considered minors in the jurisdiction where the protocol is conducted\n* Patients who are prisoners and pregnant women\n* Patients who cannot provide consent and did not sign a power of attorney",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Newly diagnosed cancer patients at the pathology level",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mihran H Shirinian, MD",
                    "role": "CONTACT",
                    "phone": "818-543-7574",
                    "email": "mshirin@aol.com"
                },
                {
                    "name": "Lily Villalobos, MHA",
                    "role": "CONTACT",
                    "phone": "818-409-8009",
                    "email": "villall3@ah.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Mihran H Shirinian, MD",
                    "affiliation": "Glendale Adventist Medical Center dba Adventist Health Glendale",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Adventist Health Glendale",
                    "status": "RECRUITING",
                    "city": "Glendale",
                    "state": "California",
                    "zip": "91206",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mihran Shirinian, M.D.",
                            "role": "CONTACT",
                            "phone": "818-543-7574",
                            "email": "mshirin@aol.com"
                        },
                        {
                            "name": "Mihran Shirinian, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.14251,
                        "lon": -118.25508
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ]
        }
    },
    "hasResults": false
}